Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

782
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
782
Long-term Depression01:03

Long-term Depression

3.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.6K
Long-term Depression01:05

Long-term Depression

33.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.8K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.2K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

348
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
348
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving In-person Interpreter Utilization in Complex Care: Findings from a Stepped-Wedge Cluster Randomized Trial of Integrated Artificial Intelligence.

Journal of general internal medicine·2026
Same author

Antipsychotic Use in Bipolar Disorder: Clinical and Genomic Correlates- A Mayo Clinic Bipolar Disorder Biobank Study.

Research square·2025
Same author

Bipolar disorder.

Lancet (London, England)·2025
Same author

Metabolic plasticity: an evolutionary perspective on metabolic and circadian dysregulation in bipolar disorder.

Molecular psychiatry·2025
Same author

Systematic Review of Second-Generation Antidepressant Monotherapy for Acute Bipolar-II Depression.

Psychopharmacology bulletin·2025
Same author

Editorial on: The Underappreciated Importance of Mania.

Acta psychiatrica Scandinavica·2025

Related Experiment Video

Updated: Apr 9, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

84.2K

Every reason to discontinue lithium.

Manuel E Fuentes Salgado1, Bruce Sutor, Robert C Albright

  • 1Department of Psychiatry and Psychology, Mayo Clinic Depression Center, Rochester, MN, 55901, USA, mfuentess@alemana.cl.

International Journal of Bipolar Disorders
|June 21, 2015
PubMed
Summary

Lithium is a gold standard treatment for bipolar disorder, but can affect kidney, parathyroid, and thyroid function. Some patients maintain mood stability for decades despite these risks, requiring individualized risk-benefit assessments.

More Related Videos

Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway
11:25

Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway

Published on: March 7, 2022

5.5K
Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries
10:41

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries

Published on: May 22, 2018

39.5K

Related Experiment Videos

Last Updated: Apr 9, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

84.2K
Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway
11:25

Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway

Published on: March 7, 2022

5.5K
Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries
10:41

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries

Published on: May 22, 2018

39.5K

Area of Science:

  • Pharmacology and Psychiatry
  • Nephrology
  • Endocrinology

Background:

  • Lithium is a primary treatment for bipolar disorder.
  • Long-term lithium use is associated with comorbidities affecting renal, parathyroid, and thyroid function.
  • Despite potential toxicities, some patients achieve decades of mood stability with lithium.

Purpose of the Study:

  • To review the long-term effects of lithium therapy in bipolar disorder.
  • To highlight the importance of monitoring end-organ function in patients on lithium.
  • To emphasize the need for individualized risk-benefit analysis in long-term lithium treatment.

Main Methods:

  • Literature review of studies on lithium therapy for bipolar disorder.
  • Analysis of patient data regarding lithium efficacy and toxicity.
  • Evaluation of renal, parathyroid, and thyroid function in long-term lithium users.

Main Results:

  • Lithium therapy can lead to significant comorbidities affecting kidney, parathyroid, and thyroid function.
  • A subset of patients demonstrate sustained mood stability over decades of lithium treatment.
  • Individualized monitoring is crucial for managing lithium's risk-benefit profile.

Conclusions:

  • Long-term lithium treatment requires careful monitoring for end-organ toxicity.
  • The therapeutic benefits of lithium for mood stability can outweigh risks in select patients.
  • Personalized risk-benefit assessments are essential for optimizing bipolar disorder management with lithium.